|Author(s)/Faculty: Martha Grogan, MD; Mathew S. Maurer, MD ; Daniel Judge, MD, FHFSA; Mazen A. Hanna, MD; Jose Nativi-Nicolau, MD, MSCI; Ronald M. Witteles, MD|
|Source: Healio Education Lab - Cardiology|
|Type: Lecture||Articles/Items: 7|
|Release Date: 1/4/2019||Expiration Date: 1/4/2020|
|Credit Type: CME / CNE||Number of Credits: 2|
|Cardiac Amyloidosis is a rare systemic disorder characterized by proteins that possess abnormal conformational features leading them to aggregate and infiltrate tissues in the form of amyloid fibrils resulting in damage to the heart and Heart Failure. Non-specific presenting symptoms and failure to recognize early signs of amyloid heart disease often lead to delay in diagnosis of Cardiac Amyloidosis. Timely diagnosis is critical to managing the disease and preventing mortality. Moreover physicians must maintain a high level of suspicion in order to make a timely diagnosis. This program will examine Cardiac Amyloidosis as a whole; while discussing patient identification, along with current and emerging treatment options.|
Click here to be redirected to access this course!